Founded in 2023, WiseDiag focuses on research and development of large AI models for healthcare, centering product and platform work on its WiseDiag multimodal medical model, the WiseClaw Agent OS, and the Haoban AI user platform. WiseDiag the model supports understanding of multiple types of medical data and is being iterated for medical report interpretation, health risk assessment, chronic disease management, and medical reasoning. WiseClaw transforms the model into configurable "Agent + Skill" modules that enterprises can integrate into workflows for tasks like report interpretation and risk assessment. Haoban AI targets individual users with services such as report interpretation, health consultation, risk alerts, and recommendations and explores online-offline conversion products. The company is actively pursuing commercial partnerships across healthcare and related industries and plans to use recent angel funding to accelerate model capabilities, product development, user growth, and enterprise scenario deployments.

Total raised

$10M

Funding rounds

1

Latest round

Equity

Latest activity

May 2026